查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1537058

抗栓塞防護襪市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2032年

Anti-Embolism Stockings Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球栓塞防護襪市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了對市場結構的詳細見解。

主要的洞察：栓塞防護襪市場

  • 市場規模（2024 年）：7.94 億美元
  • 市場預測金額（2032 年）：11.996 億美元
  • 全球市場成長率（2024-2032 年複合年增長率）：5.3%

栓塞防護襪市場 - 研究範圍：

抗栓襪在預防深部靜脈栓塞（DVT）和其他靜脈血栓栓塞（VTE）方面發揮重要作用。這些長襪逐漸壓縮腿部，增加血液循環並降低血栓形成的風險。栓塞防護襪市場面向醫院、診所、門診手術中心和家庭護理機構，提供各種襪型和壓力級別，以滿足不同患者的需求。市場成長的推動因素包括 VTE 預防意識的提高、慢性靜脈疾病盛行率的增加以及庫存材料和設計的進步。

推動市場成長的因素：

全球栓塞防護襪市場由幾個關鍵因素推動，包括醫療保健提供者和患者對 VTE 預防意識的提高。手術數量的增加以及肥胖、癌症和心血管疾病盛行率的增加，增加了 DVT 的風險，進一步推動了市場的擴張。技術進步，例如開發具有改進的透氣性、舒適性和抗菌特性的長襪，正在提高患者的依從性和治療結果，推動市場成長。此外，家庭醫療保健和預防保健的日益普及為市場參與者接觸更廣泛的患者群體開闢了新的途徑。

市場限制因素：

儘管預計栓塞防護襪市場將呈現良好的成長勢頭，但它仍面臨患者依從性、報銷政策以及來自替代 VTE 預防方法的競爭等方面的挑戰。患者持續??穿著壓力襪會因不適和不便而導致依從率低，進而影響治療效果。特別是在醫療保健預算有限的新興國家，報銷範圍有限以及栓塞防護襪價格高昂，對市場滲透構成了挑戰。應對這些挑戰需要開展教育工作以提高患者的依從性，並開展宣傳工作以改善報銷政策，以促進獲得有效的 VTE 預防解決方案。

市場機會：

在人口趨勢、技術創新和不斷發展的醫療保健服務模式的推動下，栓塞防護襪市場呈現出巨大的成長機會。世界人口老化和慢性病的增加增加了對預防性保健產品（包括栓塞防護襪）的需求。智慧紡織品和數位健康技術（例如用於即時監測壓力水平和患者依從性的可穿戴感測器）的集成，可以改善產品功能和患者治療結果。策略夥伴關係、研發投資以及採用具有成本效益且易於使用的栓塞防護襪對於利用新機會並在動態的栓塞防護領域保持市場領先地位至關重要。

本報告解決的關鍵問題

  • 推動全球抗栓襪市場成長的關鍵因素是什麼？
  • 哪些襪子類型和應用正在推動不同醫療機構採用栓塞防護襪？
  • 技術進步如何改變栓塞防護襪市場的競爭格局？
  • 誰是栓塞防護襪市場的主要參與者？
  • 全球抗栓襪市場的新趨勢與未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏事項·除外事項

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 主要成功因素

  • 主要的推銷策略:各製造廠商
  • 法規情形
  • 價值鏈分析
  • 產品採用分析
  • PESTEL分析
  • 波特分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素 - 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
    • 各產品
    • 人口統計別
    • 各終端用戶
    • 各地區
  • 2024年的市場情境

第7章 全球市場的數量(單位)分析

  • 過去的市場數量(單位)分析，2019年～2023年
  • 現在及未來市場數量(單位)預測，2024年～2032年
    • 與前一年同期比較成長趨勢分析

第8章 全球市場 - 價格分析

  • 各地區價格分析:各產品
  • 價格的明細
    • 廠商層級的價格設定
    • 分銷商層級的價格設定
  • 世界平均價格分析基準

第9章 全球市場的需求(金額或規模，一百萬美元)分析

  • 過去的市場金額(一百萬美元)分析，2019年～2023年
  • 現在及未來市場金額(一百萬美元)預測，2024年～2032年
    • 與前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第10章 全球市場分析:各產品

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各產品，2019年～2023年
  • 現在及未來市場規模(一百萬美元)分析與預測:各產品，2024年～2032年
    • 小腿長度
    • 大腿長度
  • 市場魅力分析:各產品

第11章 全球市場分析:人口統計別

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)分析:人口統計別，2019年～2023年
  • 現在及未來市場規模(一百萬美元)分析與預測:人口統計別，2024年～2032年
    • 男性
    • 女性
  • 市場魅力分析:人口統計別

第12章 全球市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)分析:各終端用戶，2019年～2023年
  • 現在及未來市場規模(一百萬美元)分析預測:各終端用戶，2024年～2032年
    • 門診病人
    • 術後患者
    • 孕婦
    • 其他
  • 市場魅力分析:各終端用戶

第13章 全球市場分析:各地區

  • 簡介
  • 過去的市場規模(一百萬美元)的分析:各地區，2019年～2023年
  • 現在及未來市場金額(一百萬美元)預測，2024年～2032年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東·非洲(MEA)
  • 各地區市場的魅力分析

第14章 北美市場分析

第15章 南美市場分析

第16章 歐洲市場分析

第17章 東亞市場分析

第18章 南亞市場分析

第19章 大洋洲市場

第20章 中東·非洲(MEA)市場分析

第21章 市場結構分析

  • 市場分析:企業各層級
  • 主要企業的市場佔有率分析
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭的詳細資訊
    • MD
    • Medtronic(Covidien)
    • Sigvaris, Medi
    • BSN Medical
    • Juzo
    • 3M
    • Bauerfeind AG
    • Thuasne Corporate
    • Pretty Legs Hosiery
    • Salzmann-Group
    • Paul Hartmann
    • Cizeta Medicali
    • Belsana Medical
    • Gloria Med
    • Zhende Medical Group
    • Maizi
    • TOKO
    • Okamoto Corporation
    • Zhejiang Sameri

第23章 所使用的前提條件與縮寫

第24章 調查手法

簡介目錄
Product Code: PMRREP33355

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Anti-Embolism Stockings Market

  • Market Size (2024E): USD 794 Million
  • Projected Market Value (2032F): USD 1199.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2032):5.3%

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings play a crucial role in the prevention of deep vein thrombosis (DVT) and other venous thromboembolic events (VTEs). These stockings apply graduated compression to the legs, enhancing blood circulation and reducing the risk of clot formation. The anti-embolism stockings market caters to hospitals, clinics, outpatient surgical centers, and homecare settings, offering a range of stocking types and compression levels to meet diverse patient needs. Market growth is driven by increasing awareness of VTE prevention, rising incidences of chronic venous disorders, and advancements in stocking materials and designs.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including the growing awareness about VTE prevention among healthcare providers and patients. The rising number of surgical procedures and the increasing prevalence of conditions such as obesity, cancer, and cardiovascular diseases, which heighten the risk of DVT, further drive market expansion. Technological advancements, such as the development of stockings with improved breathability, comfort, and antimicrobial properties, enhance patient compliance and treatment outcomes, fostering market growth. Moreover, the growing adoption of home-based care and preventive healthcare practices creates new avenues for market players to reach a broader patient population.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient compliance, reimbursement policies, and competition from alternative VTE prevention methods. Patient adherence to wearing compression stockings consistently can be low due to discomfort or inconvenience, impacting treatment efficacy. Limited reimbursement coverage for anti-embolism stockings and the high cost of premium products pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these challenges requires education initiatives to improve patient compliance and advocacy for better reimbursement policies to promote access to effective VTE prevention solutions.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by demographic trends, technological innovations, and evolving healthcare delivery models. The aging global population and the rising incidence of chronic diseases create a growing demand for preventive healthcare products, including anti-embolism stockings. The integration of smart textiles and digital health technologies, such as wearable sensors for real-time monitoring of compression levels and patient compliance, enhances product functionality and patient outcomes. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly anti-embolism stockings are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic anti-embolism landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the anti-embolism stockings market globally?
  • Which stocking types and applications are driving anti-embolism stockings adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the anti-embolism stockings market?
  • Who are the key players contributing to the anti-embolism stockings market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

Leading players in the global anti-embolism stockings market, including Sigvaris, Medi GmbH & Co. KG, and BSN Medical Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced anti-embolism stockings with enhanced comfort, durability, and therapeutic efficacy, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving anti-embolism landscape.

Key Companies Profiled:

  • Medtronic (Covidien)
  • Sigvaris
  • Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med

Anti-Embolism Stockings Industry Research Segmentation

By Product:

  • Calf-length
  • Thigh-length

By Demography:

  • Men
  • Women

By End User:

  • Ambulatory Patients
  • Post-operative Patients
  • Pregnant Women

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies by Manufacturers
  • 4.2. Regulatory Landscape
  • 4.3. Value Chain Analysis
  • 4.4. Product Adoption Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Historical Growth of Top Companies
    • 5.2.2. Adoption Rate
    • 5.2.3. Technology Advancements
    • 5.2.4. Increasing Deep Vein Thrombosis Cases
    • 5.2.5. Product Pricing
    • 5.2.6. Favorable Reimbursement Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Demography
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 10.3.1. Calf Length
    • 10.3.2. Thigh Length
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Demography

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Demography, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Demography, 2024-2032
    • 11.3.1. Men
    • 11.3.2. Women
  • 11.4. Market Attractiveness Analysis By Demography

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2024-2032
    • 12.3.1. Ambulatory Patients
    • 12.3.2. Post-Operative Patients
    • 12.3.3. Pregnant Women
    • 12.3.4. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Demography
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Demography
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Demography
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Demography
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Demography
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Demography
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Demography
        • 15.7.1.2.3. By End User
    • 15.7.2. Mexico Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Demography
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Demography
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. U.K.
      • 16.3.1.2. Germany
      • 16.3.1.3. Italy
      • 16.3.1.4. France
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. BENELUX
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Demography
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Demography
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. U.K. Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Demography
        • 16.7.1.2.3. By End User
    • 16.7.2. Germany Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Demography
        • 16.7.2.2.3. By End User
    • 16.7.3. Italy Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Demography
        • 16.7.3.2.3. By End User
    • 16.7.4. France Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Demography
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product
        • 16.7.5.2.2. By Demography
        • 16.7.5.2.3. By End User
    • 16.7.6. Russia Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product
        • 16.7.6.2.2. By Demography
        • 16.7.6.2.3. By End User
    • 16.7.7. BENELUX Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product
        • 16.7.7.2.2. By Demography
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Demography
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Demography
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Demography
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Demography
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product
        • 17.7.3.2.2. By Demography
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Demography
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Demography
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Demography
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Demography
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Demography
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Demography
        • 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Demography
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Demography
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product
        • 19.7.1.2.2. By Demography
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product
        • 19.7.2.2.2. By Demography
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Demography
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Demography
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product
        • 20.7.1.2.2. By Demography
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkiye Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product
        • 20.7.2.2.2. By Demography
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product
        • 20.7.3.2.2. By Demography
        • 20.7.3.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. MD
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Key Financials
      • 22.3.1.6. SWOT Analysis
      • 22.3.1.7. Strategy Overview
    • 22.3.2. Medtronic(Covidien)
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Key Financials
      • 22.3.2.6. SWOT Analysis
      • 22.3.2.7. Strategy Overview
    • 22.3.3. Sigvaris, Medi
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Key Financials
      • 22.3.3.6. SWOT Analysis
      • 22.3.3.7. Strategy Overview
    • 22.3.4. BSN Medical
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Key Financials
      • 22.3.4.6. SWOT Analysis
      • 22.3.4.7. Strategy Overview
    • 22.3.5. Juzo
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Key Financials
      • 22.3.5.6. SWOT Analysis
      • 22.3.5.7. Strategy Overview
    • 22.3.6. 3M
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Key Financials
      • 22.3.6.6. SWOT Analysis
      • 22.3.6.7. Strategy Overview
    • 22.3.7. Bauerfeind AG
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Key Financials
      • 22.3.7.6. SWOT Analysis
      • 22.3.7.7. Strategy Overview
    • 22.3.8. Thuasne Corporate
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Key Financials
      • 22.3.8.6. SWOT Analysis
      • 22.3.8.7. Strategy Overview
    • 22.3.9. Pretty Legs Hosiery
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Key Financials
      • 22.3.9.6. SWOT Analysis
      • 22.3.9.7. Strategy Overview
    • 22.3.10. Salzmann-Group
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Key Financials
      • 22.3.10.6. SWOT Analysis
      • 22.3.10.7. Strategy Overview
    • 22.3.11. Paul Hartmann
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Key Financials
      • 22.3.11.6. SWOT Analysis
      • 22.3.11.7. Strategy Overview
    • 22.3.12. Cizeta Medicali
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Key Financials
      • 22.3.12.6. SWOT Analysis
      • 22.3.12.7. Strategy Overview
    • 22.3.13. Belsana Medical
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Key Financials
      • 22.3.13.6. SWOT Analysis
      • 22.3.13.7. Strategy Overview
    • 22.3.14. Gloria Med
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Key Financials
      • 22.3.14.6. SWOT Analysis
      • 22.3.14.7. Strategy Overview
    • 22.3.15. Zhende Medical Group
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Key Financials
      • 22.3.15.6. SWOT Analysis
      • 22.3.15.7. Strategy Overview
    • 22.3.16. Maizi
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Key Financials
      • 22.3.16.6. SWOT Analysis
      • 22.3.16.7. Strategy Overview
    • 22.3.17. TOKO
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Key Financials
      • 22.3.17.6. SWOT Analysis
      • 22.3.17.7. Strategy Overview
    • 22.3.18. Okamoto Corporation
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Key Financials
      • 22.3.18.6. SWOT Analysis
      • 22.3.18.7. Strategy Overview
    • 22.3.19. Zhejiang Sameri
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Key Financials
      • 22.3.19.6. SWOT Analysis
      • 22.3.19.7. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology